Manish Bhandari

Angel Physicians Fund LLC engages in the health care industry. The company was founded in 2020 and is headquartered in Powell, OH.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.

Kurome Therapeutics, Inc. develops therapies that target cancer cells. The company was founded by Daniel Starczynowski and is headquartered in Cincinnati, OH.

Kurome Therapeutics, Inc. develops therapies that target cancer cells. The company was founded by Daniel Starczynowski and is headquartered in Cincinnati, OH.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.